The Federal Chamber of Psychotherapists (BPtK) has sharply criticized the decision of the Extended Evaluation...
BPtK criticizes planned reduction of psychotherapeutic fees
read more
As a medical-scientific society, the DGKL represents the interests of colleagues in clinical chemistry and laboratory medicine in Germany, Europe and the world.
The mission statement of the DGKL
The DGKL sees the health, well-being and care of patients as its driving force and top priority. The members of the DGKL guarantee fast, precise and reliable laboratory diagnostics, which form the basis for correct diagnoses, sustainable prevention and successful treatments. In the spirit of modern medicine, the members of the DGKL are fully committed to scientific progress and continuous further development of the specialist discipline, thereby guaranteeing scientific excellence. With its expertise and its national and international network, the DGKL makes a significant contribution to maintaining and continuously developing the standards of care and quality in clinical chemistry and laboratory medicine.
German Society for Clinical Chemistry and Laboratory Medicine e. V.
Alt-Moabit 96a
10559 Berlin
Phone: +49 (0)30 394 054-16
geschaeftsstelle(at)dgkl.de
Latest articles
Discover our latest articles and stay informed.
THRIVE module: StellarHeal wound care launched in space
On March 12, 2026, a REXUS research rocket was launched into the stratosphere from Sweden's Esrange Space Center. On...
Miraculous fitness probiotic: Roseburia inulinivorans massively improves muscle strength
Researchers from the University of Granada, the University of Almería and the Leiden University Medical Center have...
New imaging technique makes gene activity visible in the entire zebrafish embryo
A research team at the University of Basel has developed a new method that simulates the activity of almost 500 genes...
Roche to invest over 700 million euros in Germany in 2025
Roche invested around 719 million euros in Germany in the 2025 financial year, reaching an all-time high. Total sales...
PXR: New mechanism explains hormonal disruptions caused by chemicals
Researchers at the University of Oulu have discovered a previously unknown mechanism by which certain drugs and...
Delta-8 THC products: Study reveals inconsistent labeling and high dosages
According to a new study, products with delta-8-THC often have inconsistent and unclear labeling of the amount of...
Sildenafil shows promising effect in Leigh syndrome
An international team of researchers has identified sildenafil as a potential therapeutic agent for Leigh syndrome....
Biomarkers: Increased pTau levels in the blood not only in Alzheimer’s
Increased concentrations of the phosphorylated tau protein (pTau) in the blood, which are considered an early...
Medical Research in Iran 2026: Strong Achievements Despite Isolation
For about 15 years, Iran has been one of the countries with the world's fastest growth rate in scientific publications...
INTRODUCING: Diagnoodle – the independent comparison platform for point-of-care diagnostics
Diagnoodle is a manufacturer-independent online platform for the research and comparison of in vitro diagnostic...
Autoantibodies in the blood could predict the risk of side effects of melanoma immunotherapy
A multicenter study led by researchers from the Heidelberg Medical Faculty, the Dermato-Oncology Section of the...
New finding: Peroxiredoxins form hybrid complexes
Researchers from Saarland University, the Rhineland-Palatinate University of Technology Kaiserslautern-Landau, the...
New EU platform provides information on sustainable pharmacy
The EU-funded TransPharm consortium has launched a free, open educational website on the environmental impact of...
New President of the DGKN: Surges focuses on mobile neuromedicine
Prof. Rainer Surges, Director of the Clinic and Polyclinic for Epileptology at the University Hospital Bonn, has taken...
mio42 Update: Progress in Laboratory Findings, Patient Summary Records and European Harmonization
In a recent newsletter, mio42 GmbH has given an update on ongoing projects in the field of medical interoperability....
FU Berlin receives millions in funding for Mucus research against pandemics
Freie Universität Berlin is contributing around one million euros to the nationwide joint project "ONEMuc –...
Focus on recombinant proteins: 8th Hall Conference brings industry and science together
From 12 to 13 March 2026, the "8th Halle Conference on Recombinant Proteins" at Martin Luther University...
